A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Pharmacokinetics of ASP015KBioavailability of ASP015KHealthy Subjects
Interventions
DRUG

ASP015K

oral

Trial Locations (1)

91206

PAREXEL, Glendale

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01484964 - A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation | Biotech Hunter | Biotech Hunter